As of Feb 23
| -1.32 / -2.89%|
The 10 analysts offering 12-month price forecasts for Ionis Pharmaceuticals Inc have a median target of 44.00, with a high estimate of 65.00 and a low estimate of 17.00. The median estimate represents a -0.79% decrease from the last price of 44.35.
The current consensus among 11 polled investment analysts is to Buy stock in Ionis Pharmaceuticals Inc. This rating has held steady since February, when it was upgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.